NO20053612L - 1,2,4-triaminobenzenderivater nyttige for behandling av forstyrrelser i sentralnervesystemet - Google Patents

1,2,4-triaminobenzenderivater nyttige for behandling av forstyrrelser i sentralnervesystemet

Info

Publication number
NO20053612L
NO20053612L NO20053612A NO20053612A NO20053612L NO 20053612 L NO20053612 L NO 20053612L NO 20053612 A NO20053612 A NO 20053612A NO 20053612 A NO20053612 A NO 20053612A NO 20053612 L NO20053612 L NO 20053612L
Authority
NO
Norway
Prior art keywords
treatment
nervous system
central nervous
system disorders
derivatives useful
Prior art date
Application number
NO20053612A
Other languages
English (en)
Other versions
NO20053612D0 (no
Inventor
Mario Rottlander
Morten Bang Norgaard
Christian Wenzel Tornoe
Andreas Ritzen
Nikolay Khanzhin
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35295526&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20053612(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from PCT/DK2003/000906 external-priority patent/WO2004058739A1/en
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of NO20053612D0 publication Critical patent/NO20053612D0/no
Publication of NO20053612L publication Critical patent/NO20053612L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/20Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/28Halogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30Hetero atoms other than halogen
    • C07D333/32Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Den foreliggende oppfinnelse vedrører 1,2,4-triaminobenzenderivater med den generelle formel I eller farmasøytisk akseptable salter derav og anvendelsen derav.
NO20053612A 2002-12-27 2005-07-25 1,2,4-triaminobenzenderivater nyttige for behandling av forstyrrelser i sentralnervesystemet NO20053612L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200202012 2002-12-27
PCT/DK2003/000906 WO2004058739A1 (en) 2002-12-27 2003-12-18 1,2,4-triaminobenzene derivatives useful for treating disorders of the central nervous system

Publications (2)

Publication Number Publication Date
NO20053612D0 NO20053612D0 (no) 2005-07-25
NO20053612L true NO20053612L (no) 2005-09-23

Family

ID=35295526

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20053612A NO20053612L (no) 2002-12-27 2005-07-25 1,2,4-triaminobenzenderivater nyttige for behandling av forstyrrelser i sentralnervesystemet

Country Status (17)

Country Link
KR (1) KR20050089862A (no)
CN (1) CN100448867C (no)
AR (1) AR042656A1 (no)
BR (1) BR0317748A (no)
CL (1) CL2003002748A1 (no)
EA (1) EA008589B1 (no)
HK (1) HK1088317A1 (no)
IS (1) IS2649B (no)
MY (1) MY139844A (no)
NO (1) NO20053612L (no)
PE (1) PE20041015A1 (no)
PL (1) PL377221A1 (no)
SI (1) SI1578740T1 (no)
TW (1) TWI325414B (no)
UA (1) UA79666C2 (no)
UY (1) UY28151A1 (no)
ZA (1) ZA200504565B (no)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4200259A1 (de) * 1992-01-08 1993-07-15 Asta Medica Ag Neue 1,2,4-triaminobenzol-derivate und verfahren zu deren herstellung
DE19539861A1 (de) * 1995-10-26 1997-04-30 Asta Medica Ag Verwendung von 4-Amino-4-(4-fluorbenzylamino)-1-ethoxy-carbonylaminobenzen zur Prophylaxe und Behandlung der Folgen der akuten und chronischen zerebralen Minderdurchblutung sowie neurodegenerativer Erkrankungen
GB9915414D0 (en) * 1999-07-01 1999-09-01 Glaxo Group Ltd Medical use
US6117900A (en) * 1999-09-27 2000-09-12 Asta Medica Aktiengesellschaft Use of retigabine for the treatment of neuropathic pain
US6589986B2 (en) * 2000-12-20 2003-07-08 Wyeth Methods of treating anxiety disorders

Also Published As

Publication number Publication date
AR042656A1 (es) 2005-06-29
ZA200504565B (en) 2006-08-30
NO20053612D0 (no) 2005-07-25
BR0317748A (pt) 2005-11-22
TW200413280A (en) 2004-08-01
KR20050089862A (ko) 2005-09-08
HK1088317A1 (en) 2006-11-03
TWI325414B (en) 2010-06-01
IS7856A (is) 2005-05-23
EA008589B1 (ru) 2007-06-29
CN100448867C (zh) 2009-01-07
IS2649B (is) 2010-08-15
EA200501053A1 (ru) 2005-12-29
MY139844A (en) 2009-11-30
CL2003002748A1 (es) 2005-04-08
PE20041015A1 (es) 2005-01-08
PL377221A1 (pl) 2006-01-23
UY28151A1 (es) 2004-07-30
CN1732162A (zh) 2006-02-08
SI1578740T1 (sl) 2007-08-31
UA79666C2 (en) 2007-07-10

Similar Documents

Publication Publication Date Title
CY1106645T1 (el) Παραγωγα 1,2,4 τριαμινοβενζολης χρησιμα για τη θεραπευτικη αντιμετωπιση διαταραχων του κεντρικου νευρικου συστηματος
NO20054848L (no) Substituerte p-diaminobenzenderivater
NO20073465L (no) Benzotiazol-derivater
NO20044501L (no) [1,4] diazenino [6,7,1-IJ] kinolin-derivater som antipsykotis og antifedme-midler
TNSN05045A1 (en) Indole or benzimidazole derivatives for modulating ikappab kinase
NO20050851L (no) Kaspase-inhibitorer og anvendelser derav
NO20021328L (no) Pyrazolopyrimidier som terapeutiske midler
CY1109558T1 (el) Παραγωγα βενζο[d]αζεπινης για την θεραπεια νευρολογικων διαταραχων
PT1147110E (pt) Derivados de pirazino (aza)-indol
NO20064599L (no) Substituerte morfolin- og tiomorfolinderivater
ATE524169T1 (de) Therapeutische strategien für die prävention und behandlung der alzeheimer-krankheit
NO20052698L (no) 4(fenylpiperazinyl-metyl)benzamid-derivater og deres anvendelse ved behandling av smerte og gasatrintestinale lidelser.
NO20060020L (no) 3-fluorpiperidiner som NMDA/NR2B-antagonister
ATE402176T1 (de) Pyrrolidin- und azetidinverbindungen alsccr5- antagonisten
NO20052699L (no) 4(fenylpiperazinyl-metyl)benzamid-derivater og deres anvendelse ved behandling av smerte og gastrointestinale lidelser.
NO20062599L (no) Fremgangsmate for syntese av perindopril og farmasoytisk akseptable salter derav
NO20030724L (no) Anvendelse av derivater av valproinsyreamider og 2- valproensyreamider for terapi eller prevensjon av smerte- og/eller hodepinelidelser
FI965021A (fi) Bentsimidatsolijohdannaisia, joilla on dopaminergistä vaikutusta keskushermostossa
NO20054721L (no) Substituerte anilinderivater
NO20055758L (no) Heteroarylsubstituerte imidazolderivater som glutamatreseptorantagonister
ATE389655T1 (de) Pyrimidinderivate
FI970469A0 (fi) Bentsimidatsolijohdannaisia, joilla on dopaminerginen aktiivisuus
UA86873C2 (en) SUBSTITUTED ARYL 1,4-PYRAZlNE DERIVATIVES
MXPA05009282A (es) Derivados de anilina sustituidos.
MXPA05004273A (es) Derivados de fenilalquil y piridilalquil piperazina.

Legal Events

Date Code Title Description
CREP Change of representative

Representative=s name: PLOUGMANN & VINGTOFT, POSTBOKS 1003 SENTRUM, 0104

FC2A Withdrawal, rejection or dismissal of laid open patent application